6 results
8-K
EX-1.1
NRBO
NeuroBo Pharmaceuticals Inc
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
on the Board of Directors qualify as “independent” as defined under the rules of the Trading Market.
(oo) Cybersecurity. To the Company’s knowledge
8-K
EX-10.1
yfm67scw9 ppdz2iev
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
- Prev
- 1
- Next